The Weber Light Letter

By Robert Weber, Founder, Weber Medical Systems

From studies to practice: The latest in tPBM and laser therapy for clinicians.

Photobiomodulation | Research | Clinical Practice

Subscribe: The Weber Light Letter

The End of "Anecdotal" Light Medicine

We are officially crossing a clinical threshold. For years, photomedicine was viewed by mainstream institutions as an experimental adjunctive modality. Today, we are seeing it recognized as a foundational pillar of precision therapeutics.

Between the World Association for Photobiomodulation Therapy (WALT) publishing new frameworks to standardize clinical guidelines and the massive breakthroughs we are seeing in our own clinics, the era of guessing with light therapy is over.

---

Clinical Case Study: Reversing Refractory Crohn's Disease

We are often told that severe autoimmune conditions require a lifetime of immunosuppressants. But what happens when the strongest biologics completely stop working?

In our newest podcast episode, I sat down with my colleague and dear friend, Daniela Rueckschloss. By 2020, she was bedridden with a 10cm stricture in her ileum, maxed out on Humira and Stelara, and relying on liquid painkillers just to survive the day.

We decided to change the approach: moving from immune suppression to photodynamic repair.

The 10-Day IV "Rescue" Protocol:

• The Substrates: Daily intravenous infusions of Boswellia (a potent natural anti-inflammatory), alongside Riboflavin and Curcumin (photosensitizers that bind to pathogenic bacteria).
• The Activator: Intravenous laser blood irradiation utilizing Blue light (to trigger the photosensitizers and disinfect the microbiome), followed by Red, Green, and Yellow wavelengths to stimulate ATP production and systemic tissue repair.

 

The Result: Pathologic bowel noises ceased on day one. By day seven, she voluntarily stopped all pain medication. Today, Daniela has been 100% medication-free for over 5 years (since December 2022). She eats without restriction, travels globally, and maintains her remission with daily home-use light therapy and oral supplements.

Listen to Daniela's full clinical breakdown on the podcast here.

---

Research Radar: 3 New Shifts in Precision Photomedicine

The literature published over the last two weeks represents an unprecedented level of sophistication in our field.

1. Resolving Post-COVID "Brain Fog" (itPBM)

The recent completion of a randomized, double-blind, sham-controlled pilot trial has provided critical data on home-based itPBM (intranasal and transcranial PBM) for post-COVID cognitive impairment. Participants received 20 minutes of daily treatment targeting the brain's default mode network (DMN). Findings indicate significant cognitive benefits and improvements in attention tasks, particularly for adults under 45.

2. Antimicrobial PBM for Burn Care

A February 2026 study published in Lasers in Surgery and Medicine found that a single, brief PBM session reduced the bacterial load of acute burn wounds by 64%. Impressively, 91% of the treated wounds showed stable or improved microbial profiles. This signals a major shift toward non-antibiotic antimicrobial strategies in wound care, addressing the growing crisis of multi-drug-resistant bacteria.

3. The HANNA Framework (WALT Guidelines)

The "dosage problem" is finally being solved. WALT has officially introduced the HANNA (Holistic Analysis & Novel Normative Actions) framework. This methodology establishes standardized Clinical Practice Guidelines (CPGs) for conditions like Burning Mouth Syndrome and Trigeminal Neuralgia, replacing anecdotal reports with reproducible, Level I evidence.

---

NEXT WEEK: ISLA Conference San Diego

28th International ISLA Conference March 13th – 15th, 2026 | San Diego Mission Bay Resort

Reading the research is one thing; mastering the physical application is another.

Next week, we are bringing the global leaders of Light Medicine to California. Time is officially running out to secure your spot for our intensive, hands-on afternoon workshops covering Intravenous, Interstitial, and Transcranial applications.

Secure your last-minute ticket to ISLA San Diego here

Source & credit: By Robert Weber, Founder, Weber Medical Systems